SII in talks on fill finishing Oxford University R21 malaria vaccine in Ghana: Expert Ruchika Sharma21 April 2023 1:15 PM ISTBengaluru: Vaccine manufacturer Serum Institute of India is holding talks on fill-finishing Oxford University's R21 malaria vaccine in Ghana, which...
USFDA authorizes second Omicron-updated COVID booster for older adults Ruchika Sharma20 April 2023 4:30 PM ISTUS: The U.S. Food and Drug Administration on Tuesday authorized a second dose of Omicron-targeting COVID-19 vaccines for older adults as well as those...
Menstrual flow changes in women after COVID-19 vaccination is small and transient, researchers assure Dr. Kamal Kant Kohli18 April 2023 8:00 PM ISTUSA: The researchers in a recent study noted a small increase in the probability of greater total bleeding quantity after the first COVID-29 vaccine...
Revise Phase I/II CT protocol: CDSCO panel tells Serum Institute of India on Dengue Tetravalent Vaccine Dr. Divya Colin17 April 2023 6:00 PM ISTNew Delhi: Regarding the Phase I/II clinical trial of Dengue Tetravalent Vaccine (Live, Attenuated), the Subject Expert Committee (SEC) functional...
Moderna, Merck cancer vaccine plus Keytruda delays skin cancer return Ruchika Sharma17 April 2023 3:59 PM ISTThe vaccine is custom-built based on an analysis of a patient's tumors after surgical removal.
Surge in COVID-19 cases: Booster shot to prevent infection may do more harm than good, says AIIMS doctor Kajal Rajput17 April 2023 9:30 AM IST"There is no research on how effective the booster dose will be if you are already infected. And if this new variant is infecting you by bypassing...
Revise Phase IV CT Protocol: CDSCO panel tells Zydus Lifesciences on Typhoid Vi Conjugate Vaccine with Yellow Fever Vaccine Dr. Divya Colin15 April 2023 5:15 PM ISTNew Delhi: In response to the drug major Zydus Life Sciences' proposal to conduct Phase IV clinical for Typhoid Vi Conjugate Vaccine I.P.(TCV) with...
University of Oxford Malaria vaccine gets regulatory clearance for use in Ghana Ruchika Sharma14 April 2023 12:07 PM ISTThe vaccine has been approved for use in children aged 5 to 36 months, the age group at highest risk of death from malaria.
Flu vaccine did not meet criteria for early success in late-stage trial: Moderna Ruchika Sharma12 April 2023 1:30 PM ISTModerna President Stephen Hoge in an interview said he expected to start generating revenue from the flu vaccine in 2024, although the amount would...
Serum Institute Covovax likely to be available at Rs 225 per dose on CoWIN portal Ruchika Sharma10 April 2023 2:00 PM ISTCovovax was granted emergency-use listing by the World Health Organization on December 17, 2021.
Merck, Moderna get PRIME scheme designation from EMA for personalized mRNA cancer vaccine, KEYTRUDA combo for adjuvant treatment of High-risk Melanoma Ruchika Sharma9 April 2023 2:30 PM ISTMelanoma, the most serious form of skin cancer, is characterized by the uncontrolled growth of pigment-producing cells.
Pfizer RSV vaccine 82 percent effective in severe infection in infants: Data Ruchika Sharma7 April 2023 12:30 PM ISTFDA approval could make Pfizer's shot the first maternal vaccine available to prevent the disease in infants.
